Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer#Akeso039s #Penpulimab #Receives #NMPA #Approval #FirstLine…
Tag: FirstLine
CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline
CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO…